Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Memory Lane ...

<< Previous

Bullboard Posts

Next >>

Comment by StockingUp21on Oct 19, 2021 9:42am

142 Views

Post# 34021894

RE:Memory Lane ...

bcuz this is 7 years later and they are in same spot. What is failure if this is not. There is no trust

You should be embarassed, this is why you disappear on these days that completly prove how wrong you been all along

MrMugsy wrote: It was Feb of 2015 and and financials were just released.
A month ago, Phase 1 was halted.
The company had $900K in the bank and a market cap of $27.7M

Now, the company has 60x the cash and is valued at approx. 2x the market cap.

The weeding process is on.
You have to decide of you are in or out.
Only you can decide if you want to be a part of this.
No one is holding you or your money hostage.

----------------

For those who are missing me here - is this what you wanted to hear ?